2023 Avoca Industry Report: 360° Assessment
For more than 20 years, WCG Avoca has surveyed industry executives to gain an understanding of key trends affecting outsourced clinical development. Given that only a very small population of physicians and patients contribute to what we know about motivations and impediments toward clinical trial participation, this year’s research expanded outreach to look across all clinical research stakeholders — Sponsors, Providers, Site Staff, and Patients — regardless of their clinical trial experience, to identify opportunities for improvement of the experience for Patients and Sites.
Industry and regulatory focus on patient centricity is imperative to ensure the survival of the clinical trial industry. Most Sponsor and Provider organizations base their study designs on feedback from investigators and patients who are familiar with the clinical trial industry. In order to expand the patient pool for clinical research, Sponsors must develop protocols that meet the needs of research-naïve patients and investigators.
This report summarizes key findings to provide a 360° view on motivators and deterrents to clinical trial participation to inform decisions as we progress forward allocating resources and focus in the areas that have the greatest impact on encouraging clinical trial participation.
Click here to access The 2023 WCG Avoca State of the Industry Report: A 360° Assessment of the Clinical Trial Industry, as well as Avoca’s past research reports.